Impaired Left Ventricular Filling and All-cause Mortality in COPD
Benjamin Waschki(University of Lübeck), Mustafa Abdo(Heidelberg University), Espen E. Groth(German Center for Lung Research), Robert Bals(Ludwig-Maximilians-Universität München), F.C. Trudzinski, Tobias Welte(Medizinische Hochschule Hannover), Kathrin Kahnert(German Center for Lung Research), C. Franz Vogelmeier(Philipps University of Marburg), Henrik Watz(University of Lübeck), A. Kirsten(LungenClinic Grosshansdorf), Peter Alter(Philipps University of Marburg), RA Jörres(LMU Klinikum), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel)
Cited by 0
Related Papers
Clinical and economic burden of community-acquired pneumonia among adults in Europe
|Thorax|2010|1.1k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
|The Lancet Respiratory Medicine|2020|864
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679